Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab

A. M. Vignola, J. Bousquet, J. Maspero, H. Fox, S. Hedgecock, M. Blogg (Palermo, Italy; Montpellier, France; Buenos Aires, Argentina; Horsham, United Kingdom)

Source: Annual Congress 2003 - Newer and alternative non-steroidal treatments for asthmatic inflammation
Session: Newer and alternative non-steroidal treatments for asthmatic inflammation
Session type: Oral Presentation
Number: 1388
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Vignola, J. Bousquet, J. Maspero, H. Fox, S. Hedgecock, M. Blogg (Palermo, Italy; Montpellier, France; Buenos Aires, Argentina; Horsham, United Kingdom). Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab. Eur Respir J 2003; 22: Suppl. 45, 1388

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omalizumab in the treatment of perennial allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 37s
Year: 2001

The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Levocetirizine in the treatment of perennial allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002

Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 121s
Year: 2006

Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis
Source: Eur Respir J 2004; 24: 330
Year: 2004


Impact of allergic rhinitis on asthma
Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy
Year: 2012



Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


Diagnosis and treatment of allergic rhinitis in asthmatic children
Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children
Year: 2009


Asthma among allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003

The effect of cockroach-sensitivity on allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 436s
Year: 2001

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
Source: Eur Respir J 2002; 20: 73-78
Year: 2002



Is montelukast effective in allergic rhinitis in children?
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006